Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on July 8, 2002

Circulation. 2002
Published online before print July 8, 2002, doi: 10.1161/01.CIR.0000025631.68522.9D
A more recent version of this article appeared on August 13, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/7/831    most recent
01.CIR.0000025631.68522.9Dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bengel, F. M.
Right arrow Articles by Schwaiger, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bengel, F. M.
Right arrow Articles by Schwaiger, M.
Related Collections
Right arrow Nuclear cardiology and PET
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy

Submitted on March 6, 2002
Revised on May 23, 2002
Accepted on May 25, 2002

Clinical Determinants of Ventricular Sympathetic Reinnervation After Orthotopic Heart Transplantation

Frank M. Bengel MD*, Peter Ueberfuhr MD, Thomas Hesse MS, Nina Schiepel MS, Sibylle I. Ziegler PhD, Siegfried Scholz MD, Stephan G. Nekolla PhD, Bruno Reichart MD, and Markus Schwaiger MD

From Nuklearmedizinische Klinik und Poliklinik der Technischen Universität (F.M.B., T.H., N.S., S.I.Z., S.G.N., M.S.), Herzchirurgische Klinik der Ludwig-Maximilians-Universität (P.U., B.R.), and Labor für Immungenetik der Ludwig-Maximilians-Universität (S.S.), Munich, Germany.

* To whom correspondence should be addressed. E-mail: frank.bengel{at}lrz.tu-muenchen.de.

Background—It has been demonstrated that ventricular sympathetic reinnervation after cardiac transplantation improves exercise performance. The extent of reinnervation increases with time but is variable. Little is known about other influencing factors.

Methods and Results—Seventy-seven nonrejecting transplant recipients were cross-sectionally studied by PET with the catecholamine analogue C-11 hydroxyephedrine at 4.8±3.5 years after transplantation. Results were compared with history-derived parameters related to recipient's clinical course before, during, and after surgery; donor characteristics; and immunogenetics. Partial reinnervation was observed in 52 patients (extent, 21±16% of left ventricle). Complete denervation was found in 25 patients at various times after transplantation. Reinnervation extent correlated with time after surgery (r=0.387; P<0.001) but also inversely with donor age (r=-0.309, P=0.006) and recipient age (r=-0.243, P=0.032). Maximal hydroxyephedrine retention correlated inversely with frequency of rejection episodes (r=-0.267, P=0.019), was reduced when aortic complications occurred perioperatively (9 patients), and correlated inversely with aortic cross-clamp time (r=-0.331, P=0.006). Other parameters were not associated with reinnervation. Patients were surveyed for clinical complications over >12 months after PET (until 7.3±4.2 years after transplantation), but significant effects of reinnervation on outcome were not observed.

Conclusions—The present data suggest that sympathetic reinnervation after cardiac transplantation is not simply a function of time. Reinnervation is more likely with young age, fast and uncomplicated surgery, and low rejection frequency. Despite few effects on prognosis in otherwise healthy recipients, improved understanding of clinical determinants may contribute to enhance allograft reinnervation and thereby augment exercise capacity in the future.


Key words: nervous system, sympathetic • transplantation • tomography




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. B. Marko and D. H. Damon
VEGF promotes vascular sympathetic innervation
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2646 - H2652.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. M. Bengel, P. Ueberfuhr, D. Schafer, S. G. Nekolla, B. Reichart, and M. Schwaiger
Effect of Diabetes Mellitus on Sympathetic Neuronal Regeneration Studied in the Model of Transplant Reinnervation
J. Nucl. Med., September 1, 2006; 47(9): 1413 - 1419.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. J. Luisi Jr., G. Suzuki, R. deKemp, M. S. Haka, S. A. Toorongian, J. M. Canty Jr., and J. A. Fallavollita
Regional 11C-Hydroxyephedrine Retention in Hibernating Myocardium: Chronic Inhomogeneity of Sympathetic Innervation in the Absence of Infarction
J. Nucl. Med., August 1, 2005; 46(8): 1368 - 1374.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F. M. Bengel, P. Ueberfuhr, J. Karja, K. Schreiber, S. G. Nekolla, B. Reichart, and M. Schwaiger
Sympathetic reinnervation, exercise performance and effects of {beta}-adrenergic blockade in cardiac transplant recipients
Eur. Heart J., October 1, 2004; 25(19): 1726 - 1733.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. S. Lovric, V. Avbelj, R. Trobec, D. Zorman, P. Rakovec, S. Hojker, B. Gersak, and M. Milcinski
Sympathetic reinnervation after heart transplantation, assessed by iodine-123 metaiodobenzylguanidine imaging, and heart rate variability
Eur. J. Cardiothorac. Surg., October 1, 2004; 26(4): 736 - 741.
[Abstract] [Full Text] [PDF]